Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway-Reference-Cited by-同舟云学术

Licochalcone A alleviates laser-induced choroidal neovascularization by inhibiting the endothelial-mesenchymal transition via PI3K/AKT signaling pathway

Published:2023-01 Issue: Volume:226 Page:109335
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Zhang Yan,Zhou Si-Qi,Xie Meng-Meng,jiang Qiu-Le,Yang Ning,Wu Rui,Zhou Jie,Xu Xin-Rong

Funder

National Natural Science Foundation of China

Jiangsu Provincial Key Research and Development Program

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference37 articles.

1. Recurrence rate of choroidal neovascularization in neovascular age-related macular degeneration managed with a Treat-Extend-Stop protocol;Adrean;Ophthalmol. Retina,2018

2. Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p;Bai;Sci. Rep.,2021

3. Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes;Campa;Invest. Ophthalmol. Vis. Sci.,2008

4. Mechanistic studies on the role of TGF-beta1 in angiogenesis through EndMT;Cao;Vascular,2021

5. Age-related macular degeneration: epidemiology, genetics, pathophysiology, diagnosis, and targeted therapy;Deng;Genes Dis.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Furin knockdown inhibited EndMT and abnormal proliferation and migration of endothelial cells;Clinical Hemorheology and Microcirculation;2024-09-05

2. Platelets could be key regulators of epithelial/endothelial-to- mesenchymal transition in atherosclerosis and wound healing;Medical Hypotheses;2024-08

3. Licochalcone A induces mitochondria-dependent apoptosis and interacts with venetoclax in acute myeloid leukemia;European Journal of Pharmacology;2024-04